Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q3 2025 Earnings Call Transcript November 12, 2025 Atea Pharmaceuticals, Inc.
The U.S. Food and Drug Administration announced it is taking action to approve new labeling submitted by the company that includes the addition of ...
Money market funds in Kenya have quietly transformed from niche capital market products into the most powerful savings engines in the country ...
The drug information sheets that the FDA requires companies to produce are living documents that get updated with new ...
The U.S. Food and Drug Administration said on Friday it approved new labeling for Sarepta Therapeutics' gene therapy Elevidys ...
The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year.
A gene therapy for Duchenne muscular dystrophy caused complications to the liver, prompting a review of its use for younger patients.
(NAPSI)—When winter weather comes, the Outdoor Power Equipment Institute (OPEI) encourages home and business owners to review ...
People are also reading… More new shops open at Lighthouse Place Premium Outlets in Michigan City Chicagoans, enter now for your chance to win tickets to JoJo’s Friendsgiving on Wednesday, Nov. 19 ...
The agency is cautioning patients about the risk of serious, possibly fatal, liver injuries and has limited the gene therapy's use to ambulatory patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback